Larsen, Scott D.

Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence

Zheng, H., Colvin, C. J., Johnson, B. K., Kirchhoff, P. D., Wilson, M., Jorgensen-Muga, K., Larsen, S. D., & Abramovitch, R. B. (2017) · Nature Chemical Biology

Tuberculosis Research and EpidemiologyBacterial Genetics and Biotechnology

Cited by 169

Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury

Haak, A. J., Tsou, P.-S., Amin, M. A., Ruth, J. H., Campbell, P., Fox, D. A., Khanna, D., Larsen, S. D., & Neubig, R. R. (2014) · The Journal of Pharmacology and Experimental Therapeutics

Systemic Sclerosis and Related DiseasesTGF-β signaling in diseases

Cited by 103

Thermodynamic and Structure Guided Design of Statin Based Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase

Sarver, R. W., Bills, E., Bolton, G., Bratton, L. D., Caspers, N. L., Dunbar, J. B., Harris, M. S., Hutchings, R. H., Kennedy, R. M., Larsen, S. D., et al. (2008) · Journal of Medicinal Chemistry

Cancer, Lipids, and Metabolismthermodynamics and calorimetric analyses

Cited by 65